Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-120,924
Closed -$11.1M 299
2025
Q2
$11.1M Sell
120,924
-1,104
-0.9% -$101K 0.03% 386
2025
Q1
$10.7M Sell
122,028
-11,080
-8% -$1.09M 0.04% 370
2024
Q4
$12.3M Buy
133,108
+24,944
+23% +$2.4M 0.04% 350
2024
Q3
$10M Sell
108,164
-3,362
-3% -$282K 0.03% 394
2024
Q2
$8.36M Sell
111,526
-6,477
-5% -$517K 0.02% 421
2024
Q1
$10.2M Sell
118,003
-1,817
-2% -$139K 0.03% 403
2023
Q4
$8.29M Sell
119,820
-127,243
-52% -$7.68M 0.03% 436
2023
Q3
$13.5M Buy
+247,063
New +$14M 0.05% 336
2021
Q1
Sell
-577
Closed -$25K 1232
2020
Q4
$25K Hold
577
﹤0.01% 1243
2020
Q3
$21K Buy
+577
New +$21.7K ﹤0.01% 1254

Other funds holding CRH

Axa's CRH Position: Q3 2025 in Review

Axa sold out of CRH (CRH) in Q3 2025, closing a stake of 120,924 shares — an estimated $11.1M sold.

Axa first reported a position in CRH in Q3 2020 and held it in 10 quarters. The position peaked at $13.5M in Q3 2023. 932 funds tracked by Wall St. Rank hold CRH as of Q3 2025.

  • Axa reported no remaining CRH position as of Q3 2025 after selling out during the quarter.
  • Axa sold 120,924 CRH shares in Q3 2025, an estimated $11.1M.
  • Axa first reported a position in CRH in Q3 2020 and held it in 10 quarters.
  • Axa's CRH position peaked at $13.5M in Q3 2023.
  • 932 funds tracked by Wall St. Rank held CRH as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.